课题基金 / 基金详情

B FRAGILIS MULTIPLE DRUG RESISTANCE--ORGIN AND CONTROL

B FRAGILIS MULTIPLE DRUG RESISTANCE--ORGIN AND CONTROL
脆弱拟杆菌多重耐药性--起源与控制
批准号:
2671978
负责人:
CHARLES J. SMITH
金额:
$14.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-04-01 至 2000-08-31

项目摘要

项目成果

CHARLES J. SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): This proposal is a continuation of ongoing studies into the mechanisms of antibiotic-resistance gene structure, expression, and transfer in Bacteroides spp. These organisms are important components of the normal flora of the extremes of the gastrointestinal tract and are substantially phylogenetically diverged from other common human bacterial pathogens. Bacteroides fragilis, in particular, is an important pathogen with a propensity for abscess formation. Antimicrobial resistance has developed to many B-lactams and other drugs used to treat these organisms. The long term goal of the project is to elucidate the novel mechanisms that regulate expression of antibiotic resistance and virulence in these organisms and the systems that contribute to the dissemination of resistance genes. Dr. Smith's prior work identified the hybrid promoter structure of B-lactamase gene, cepA, involving IS1224 in strains expressing high and low levels of B-lactamase and has defined the common occurrence of apparent IS elements just upstream of antibiotic-resistance gene promoters. He has also cloned and characterized two other B-lactamase genes from Bacteroides spp. and characterized the structure of the mobilizable cefoxitin-resistance transposon element Tn4555, its Mob region, and its apparent oriT site, which is required in cis for transfer by conjugation. Tn4555 appears to differ from the previously reported NBU1 element. The specific aims of the current proposal are first to determine the mechanisms activating expression of the antibiotic resistance genes using the B. fragilis cepA gene as a model. Under this aim Dr. Smith will delineate the cepA::IS1224 hybrid promoter, perform structural analysis on IS-linked promoters, and define the mechanisms involved in IS1224 transposition. Under the second aim Dr. Smith proposes to define the mechanisms responsible for the dissemination of broad-spectrum B-lactam resistance in Bacteroides. For this he will focus on Tn4555 and the requirements for its mobilization for conjugation and for its transposition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
METALLIC NANOPARTICLES AS THERAPEUTIC CANCER PROBES
  • 批准号:
    7721540
  • 项目类别:
  • 资助金额:
    $0.04万
  • 财政年份:
    2008
  • 负责人:
    CHARLES J. SMITH
  • 依托单位:
ROLE OF B.FRAGILIS OXYGEN STRESS RESPONSE IN INFECTION
  • 批准号:
    7318334
  • 项目类别:
  • 资助金额:
    $26.51万
  • 财政年份:
    1998
  • 负责人:
    CHARLES J. SMITH
  • 依托单位:
ROLE OF B.FRAGILIS OXYGEN STRESS RESPONSE IN INFECTION
  • 批准号:
    6986156
  • 项目类别:
  • 资助金额:
    $27.83万
  • 财政年份:
    1998
  • 负责人:
    CHARLES J. SMITH
  • 依托单位:
ROLE OF B.FRAGILIS OXYGEN STRESS RESPONSE IN INFECTION
  • 批准号:
    8036989
  • 项目类别:
  • 资助金额:
    $31.78万
  • 财政年份:
    1998
  • 负责人:
    CHARLES J. SMITH
  • 依托单位:
海外基金